Hutchmed (China) Logs Lower H1 Net Income; Revenue Rises

MT Newswires · 1d ago
07:17 AM EDT, 07/30/2026 (MT Newswires) -- Hutchmed (China) (HCM.L) said Thursday its net income for the first half dropped, while revenue rose year over year. Net income attributable to Hutchmed for the six months ended June 30 was $15.9 million, compared with $455 million a year earlier. EPS moved to $0.02 from $0.52. The biopharmaceutical company's total revenue was $278.3 million, compared with $277.7 million a year ago. The company maintained its outlook for the full year and still expects oncology/immunology consolidated revenue between $330 million and $450 million.